EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 59 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.54 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $23,000 | – | 14,057 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 41,909,219 | $21,793,000 | 11.58% |
| Kore Private Wealth LLC | 202,366 | $105,000 | 0.02% |
| BARD ASSOCIATES INC | 335,750 | $175,000 | 0.02% |
| HighTower Advisors, LLC | 5,284,688 | $2,738,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 126,529 | $66,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 654,200 | $339,000 | 0.01% |
| Virtu Financial LLC | 57,076 | $30,000 | 0.01% |
| WEDBUSH SECURITIES INC | 81,500 | $42,000 | 0.00% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 33,933 | $18,000 | 0.00% |
| MATRIX ASSET ADVISORS INC/NY | 39,500 | $20,000 | 0.00% |